FDA Compliance
-
Sale!
U.S. FDA New Draft Guidance on UDI Label Form and Requirement
The U.S. FDA is well into their long-anticipated Unique Device Identification System. Its purpose is to “establish a system to adequately identify devices through distribution and use”. It requires the development of a unique device identifier (UDI) in plain... -
U.S. FDA’s 510(k), IDE, and PMA Documentation, Submission and Approval Process
What are the various routes to US FDA device clearance / approval? The majority of medical devices are cleared for marketing in the U.S. by the FDA under the 510(k) process, others are exempt, and some must go through... -
UDI Implementation – What is required ?
The US FDA has published the final regulations for Unique Device Identification (UDI). Manufacturers must start implementation planning. UDI implementation requires understanding of several major steps: Producing compliant device labels, packaging Uploading the appropriate information into the GUIDID Updating... -
Understanding Aseptic Technique and Cleanroom Behavior – Avoiding Human Error
Compounded sterile products are made utilizing aseptic technique. Aseptic technique is a microbiological term referring to the prevention of microorganism contamination. Most importantly, this activity is critical for the successful manufacture of safe and sterile therapeutics. The procedure involves... -
Understanding Medical Device Design Controls
Design Controls are the processes used to design, develop, and manage medical devices that you manufacture. They are mandated by federal regulation however the regulations concerning design controls are vague in terms of the specific process steps required and... -
Sale!
Understanding the Final FDA Guidance for Validation of Analytical Methods
Recently the FDA has released a new comprehensive guidance for validation of analytical methods. The guidance applies the modern integrated lifecycle approach with related new requirements for using quality-by-design components, risk assessment, design space and continuous improvement. The guidance... -
Sale!
US FDA 510(k) – Latest Guidance, Due Diligence, Preparation, Submission and Clearance
The United States Food and Drug Administration (FDA) recently issued final 510(k) guidance, providing FDA’s policy on the 510(k) program. This seminar will provide a great opportunity to get familiar with how to best prepare for a 510(k) for... -
US FDA Drug Review and Approval Process – Understanding the Latest Regulations
Why You Should Attend : The FDA’s Center for Drug Evaluation and Research (CDER) is responsible for reviewing and approving both prescription and nonprescription or over-the-counter (OTC) drugs. To introduce a new drug product into the U.S. market, some... -
US RAC Exam – How to Prepare Most Effectively
ACCREDITATION: Course “US RAC Exam – How to Prepare Most Effectively” has been pre-approved by RAPS as eligible for up to 1.5 credits towards a participant’s RAC recertification upon full completion. Having a credential for Regulatory Affairs Certification... -
US vs EU – Medical Devices Compliance and Regulatory Affairs
This webinar will provide an understanding of the structure of both US and EU regulatory bodies. The regulatory content common to all regulations will be addressed to create a foundation for understanding the basics of medical device compliance regulations.... -
USFDA’s 2019 – 2020 Strategic Priorities
This webinar will examine the FDA’s “Strategic Priorities” and related initiatives, with emphasis on 2019-2020. Such a review will focus on the broad range of issues a company’s senior management and QA/RA need to consider in their annual Management... -
USP <1224> Transferring the Method to meet Regulatory Expectations
When transferring validated methods between laboratories and sites, their validated states must be maintained to safeguard the exact consistent results in the receiving laboratory. The critical points of USP <1224> are very specific on the requirements for technology transfer... -
Valid Statistical Rationales for Sample Sizes
This webinar explains the logic behind sample-size choice for several statistical methods that are commonly used in verification or validation efforts, and how to express a valid statistical justification for a chosen sample size. Almost all manufacturing and development... -
Valid Statistical Rationales for Sample Sizes
This webinar explains the logic behind sample-size choice for several statistical methods that are commonly used in verification or validation efforts, and how to express a valid statistical justification for a chosen sample size. Almost all manufacturing and development... -
Validation and Control of Excel® Spreadsheets in Regulated Environments
Excel® Applications are widely used in laboratories, offices and manufacturing e.g., for data capture, data manipulation and report generation. Regulations such as HIPAA, Sarbanes Oxley Act and FDA’s GxP and 21 CFR Part 11 require users of software and... -
Validation and Control of Excel® Spreadsheets in Regulated Environments
Excel® Applications are widely used in laboratories, offices and manufacturing e.g., for data capture, data manipulation and report generation. Regulations such as HIPAA, Sarbanes Oxley Act and FDA’s GxP and 21 CFR Part 11 require users of software and...